SHOULDER INNOVATIONS, INC.

SI ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024
Revenue $47.3M $31.6M
Cost of Revenue $11.1M $7.3M
Gross Profit $36.2M $24.3M
Gross Margin 76.5% 77.0%
Operating Expenses
Research & Development $7.7M $4.5M
SG&A Expense $54.8M $34.5M
Operating Income $-26.3M $-14.7M
Operating Margin -55.6% -46.3%
Interest Expense
Pretax Income $-40.4M $-15.6M
Income Tax Expense $0 $0
Net Income $-40.4M $-15.6M
Net Margin -85.3% -49.4%
EPS (Basic) $-4.65 $-1.81
EPS (Diluted) $-4.65 $-1.81
Shares Outstanding (Basic) 8.7M 8.6M
Shares Outstanding (Diluted) 8.7M 8.6M
Dividends Per Share